Quotables
"I watched his countenance closely, to see if he was not deranged ... and I was assured by other senators after he left the room that they had no confidence in it."
U.S. Senator Smith of Indiana ; After seeing Samuel Morse demonstrate the telegraph.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8044035 | Pharmaceutical compositions of pyrimidine-2,4,6-triones A trioxopyrimidine-cyclodextrin complex formed of a trioxopyrimidine derivative or a salt thereof and a water-soluble cyclodextrin derivative has improved solubility. ... | 10/25/2011 |
| 8009918 | Visual background extractor The present invention relates to a Visual Background Extractor (VIBE) consisting in a method for detecting a background in an image selected from a plurality of related images. Each one of said set of images is formed by a set of pixels, and captured by an imaging d... | 08/30/2011 |
| 7959912 | Probiotic bifidobacterial species A probiotic composition comprising a Bifidobacterium strain which has DNA sequence homology of greater than 40% to Bifidobacterium GC56, wherein Bifidobacterium GC56 was deposited at the Collection Nationale de Cultures de Micro-organismes (CNCM... | 06/14/2011 |
| 7829550 | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases The invention provides the use of a cyclodextrin compound for the manufacturing of a medicament for the treatment or prevention of bronchial inflammatory diseases, particularly for asthma. ... | 11/09/2010 |
| 7745193 | Hybrid proteins of active-site serine β-lactamase The present invention refers to a recombinant nucleotide sequence which codes upon expression for at least a part of a bifunctional hybrid active-site serine β-lactamase protein, wherein the β-lactamase protein is bearing at least one heterologous sequence, wherei... | 06/29/2010 |
| 7655626 | Antiangiogenic peptides The present invention refers to a pharmaceutical composition comprising an isolated antiangiogenic peptide or a recombinant protein comprising the antiangiogenic peptide, wherein the peptide is between 11 and 40 amino acids in length and having antiangiogenic activi... | 02/02/2010 |
| 7507761 | Benzopyran derivatives, method of production and use thereof The invention relates to novel benzopyran derivatives of formula I, to their method of production, to composition comprising the derivatives and use thereof. wherein: R1, R2, R3 an... | 03/24/2009 |
